WAUN KI HONG announced his plans to retire as head of the MD Anderson Cancer Center Division of Cancer Medicine effective this summer after 30 years at that institution. Hong is 71.
In a recent article published in the Journal of Oncology Practice, oncologists Ray Drasga and Lawrence Einhorn called on their colleagues to support “an improved Medicare for all” program.
Studies assessing the merits of cancer screening tend to get a lot of play in the news media. It seems every six months or so a new study makes a big splash.
A meeting of the FDA Oncologic Drugs Advisory Committee has become a rare occurrence.
AMGEN and MERCK announced an agreement to evaluate the safety and efficacy of talimogene laherparepvec, an investigational oncolytic immunotherapy, combined with MK-3475, an investigational anti-PD-1 immunotherapy, in a phase Ib/II study in mid- to late-stage melanoma.
HEALTH CANADA approved the Aptima HPV 16 18/45 genotype assay for use on the Panther system, both developed by Hologic Inc. The assay is the only approved test for genotyping human papillomavirus types 16, 18 and/or 45 in Canada.
DEFINIENS and Clarient Diagnostic Services Inc. signed an agreement to extend the use of Definiens' automated image analysis software and solutions in Clarient's validated clinical applications for immunohistochemistry testing in breast cancer.
THE UNIVERSITY OF PITTSBURGH selected GenomOncology's GenomAnalytics platform and services to explore and mine the data in The Cancer Genome Atlas.
SARAH CANNON CANCER CENTER and HealthONE hospitals launched an initiative to fully integrate their cancer programs by the end of 2014.
RICHARD FOLKERS was named director of communications for the Foundation for the NIH.
